Literature DB >> 22037460

Oct4-related cytokine effects regulate tumorigenic properties of colorectal cancer cells.

Charn-Jung Chang1, Yueh Chien, Kai-Hsi Lu, Shih-Ching Chang, Yueh-Ching Chou, Chi-Shuan Huang, Chin-Hong Chang, Kuan-Hsuan Chen, Yuh-Lih Chang, Ling-Ming Tseng, Wen-Shin Song, Jhi-Joung Wang, Jen-Kou Lin, Pin-I Huang, Yuan-Tzu Lan.   

Abstract

Oct4, a member of the POU-domain transcription factor family, has been implicated in the cancer stem cell (CSC)-like properties of various cancers. However, the precise role of Oct4 in colorectal CSC initiation remains uncertain. Numerous studies have demonstrated a strong link between inflammation and tumorigenesis in colorectal cancers. In this study, we demonstrated that Oct4 overexpression enhances CSC-like properties of colorectal cancer cells (CRCs), including sphere formation, cell colony formation, cell migration, invasiveness, and drug resistance. In addition, putative CSC markers, stemness genes, drug-resistant genes, as well as interleukin (IL)-8 and IL-32 were upregulated. Microarray-based bioinformatics of CRCs showed higher expression levels of embryonic stem cell-specific genes in cells that overexpressed Oct4. Neutralization of either IL-8 or IL-32 with specific antibodies partially blocked the tumorigenic effects induced by either Oct4 overexpression or by the addition of conditioned media from Oct4-overexpressing CRCs. In addition, the presence of Oct4-overexpressing CRCs enhanced the tumorigenic potential of parental CRCs in vivo. In summary, these data suggest that IL-8 and IL-32 play a role in regulating the CSC-like properties that promote tumorigenesis of CRCs in both autocrine and paracrine manners.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22037460     DOI: 10.1016/j.bbrc.2011.10.024

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

Review 1.  Hallmarks in colorectal cancer: angiogenesis and cancer stem-like cells.

Authors:  Muriel Mathonnet; Aurelie Perraud; Niki Christou; Hussein Akil; Carole Melin; Serge Battu; Marie-Odile Jauberteau; Yves Denizot
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

2.  IL-32α-induced inflammation constitutes a link between obesity and colon cancer.

Authors:  Victoria Catalán; Javier Gómez-Ambrosi; Amaia Rodríguez; Beatriz Ramírez; Victor A Ortega; José Luis Hernández-Lizoain; Jorge Baixauli; Sara Becerril; Fernando Rotellar; Víctor Valentí; Rafael Moncada; Camilo Silva; Javier Salvador; Gema Frühbeck
Journal:  Oncoimmunology       Date:  2017-05-16       Impact factor: 8.110

Review 3.  Influence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvironment.

Authors:  Claudia Palena; Duane H Hamilton; Romaine I Fernando
Journal:  Future Oncol       Date:  2012-06       Impact factor: 3.404

4.  Increasing the colon cancer cells sensitivity toward radiation therapy via application of Oct4-Sox2 complex decoy oligodeoxynucleotides.

Authors:  Behrooz Johari; Hamed Rezaeejam; Mohammad Moradi; Zahraa Taghipour; Zohreh Saltanatpour; Yousef Mortazavi; Leila Nasehi
Journal:  Mol Biol Rep       Date:  2020-08-31       Impact factor: 2.316

5.  Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells.

Authors:  Seog-Young Kim; Jin Wook Kang; Xinxin Song; Bo Kyoung Kim; Young Dong Yoo; Yong Tae Kwon; Yong J Lee
Journal:  Cell Signal       Date:  2013-01-16       Impact factor: 4.315

Review 6.  Cancer stem cells in human digestive tract malignancies.

Authors:  Fatemeh B Rassouli; Maryam M Matin; Morvarid Saeinasab
Journal:  Tumour Biol       Date:  2015-10-07

Review 7.  Role of interleukin-32 in cancer biology.

Authors:  Haimeng Yan; Donghua He; Xi Huang; Enfan Zhang; Qingxiao Chen; Ruyi Xu; Xinling Liu; Fuming Zi; Zhen Cai
Journal:  Oncol Lett       Date:  2018-05-07       Impact factor: 2.967

8.  OCT4 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells by miR-125b/BAK1 pathway.

Authors:  Y-D Wang; N Cai; X-L Wu; H-Z Cao; L-L Xie; P-S Zheng
Journal:  Cell Death Dis       Date:  2013-08-08       Impact factor: 8.469

9.  Autochthonous mouse melanoma and mammary tumors do not express the pluripotency genes Oct4 and Nanog.

Authors:  Caroline Schreiber; Vanessa Kuch; Viktor Umansky; Jonathan P Sleeman
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

10.  Epigenetic Mechanism of Enrichment of A549 Lung Cancer Stem Cells with 5-Fu.

Authors:  Fangyuan Cao; Mumu Shi; Bo Yu; Xiangrong Cheng; Xin Li; Xinshan Jia
Journal:  Onco Targets Ther       Date:  2021-06-18       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.